| ★ | HCPLive Five: Maui Derm NP+PA Summer 2026 | | 20 | Estados Unidos | |
| 16 | Homicidios aumentaron un 42,3% en los últimos 28 días | CNN Prime | | 1.3K | Chile | 51 |
| 10 | TMS for Depression Is Changing Fast | What Psychiatrists Need to Know | | 774 | Estados Unidos | 52 |
| 3 | Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | 55 |
| 17 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 51 |
| 8 | AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD | | 129 | Estados Unidos | 52 |
| 13 | Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD | | 113 | Estados Unidos | 51 |
| 5 | The Only FDA-Approved Peanut OIT Is Discontinued. Now What? | | 99 | Estados Unidos | 53 |
| 7 | What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis? | | 92 | Estados Unidos | 52 |
| 6 | What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 53 |
| 9 | 2026 Dyslipidemia Guidelines Redefine Treatment, Monitoring Strategies, With Roger Blumenthal, MD | | 71 | Estados Unidos | 52 |
| 2 | ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More | HCPLive Expert Interviews | | 70 | Estados Unidos | 58 |
| 1 | ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More | HCPLive Expert Interviews | | 55 | Estados Unidos | 61 |
| 14 | What Factors Should Guide Atopic Dermatitis Treatment Selection? With Walter Liszewski, MD | | 46 | Estados Unidos | 51 |
| 15 | The Influence of Physician Role Models on Young Patients, With Lisa Swanson, MD | | 43 | Estados Unidos | 51 |
| 19 | POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP | | 35 | Estados Unidos | 50 |
| 18 | Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD | | 29 | Estados Unidos | 51 |
| 12 | Does Transplant Center Choice Impact Kidney Transplant Evaluation Chances? | | 25 | Estados Unidos | 52 |
| 11 | Is Atopic Dermatitis Due to Environment or Genetics? With Matthew Zirwas, MD | | 23 | Estados Unidos | 52 |
| 4 | The Cost of Delay: How Prior Authorization Is Impacting Dermatology | | 12 | Estados Unidos | 53 |
| 20 | 2025 - Dr Javier Arellano "Enfermedades Asociadas a la Dermatitis" | Creciendo Con Alergias y En Tu Piel @fundacioncreciendoconalergias | 12 | Chile | 50 |